505(b)(2) Type innovations in liquid-filled hard capsules
The introduction of the 505(b)(2) application pathway by the USFDA has turned out to be a game-changer for pharma companies. Not only has it led to faster drug approvals compared…
The introduction of the 505(b)(2) application pathway by the USFDA has turned out to be a game-changer for pharma companies. Not only has it led to faster drug approvals compared…